Non-Operative Options for Loco-regional Melanoma.
Publication
, Journal Article
Knackstedt, R; Smile, T; Yu, J; Gastman, BR
Published in: Clin Plast Surg
October 2021
Malignant melanoma is the 5th most common cancer and stage IV melanoma accounts for approximately 4% of new melanoma diagnoses in the United States. The prognosis for regionally advanced disease is poor, but there have been numerous recent advances in the medical management of melanoma in-transit metastases. The goal of this paper is to review currently accepted treatment options for in-transit metastases and introduce emerging therapies. Therapies to be discussed include limb perfusion and infusion, immunotherapy, checkpoint inhibitors, and radiation therapy.
Duke Scholars
Published In
Clin Plast Surg
DOI
EISSN
1558-0504
Publication Date
October 2021
Volume
48
Issue
4
Start / End Page
631 / 642
Location
United States
Related Subject Headings
- United States
- Surgery
- Skin Neoplasms
- Melanoma
- Immunotherapy
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Knackstedt, R., Smile, T., Yu, J., & Gastman, B. R. (2021). Non-Operative Options for Loco-regional Melanoma. Clin Plast Surg, 48(4), 631–642. https://doi.org/10.1016/j.cps.2021.05.007
Knackstedt, Rebecca, Timothy Smile, Jennifer Yu, and Brian R. Gastman. “Non-Operative Options for Loco-regional Melanoma.” Clin Plast Surg 48, no. 4 (October 2021): 631–42. https://doi.org/10.1016/j.cps.2021.05.007.
Knackstedt R, Smile T, Yu J, Gastman BR. Non-Operative Options for Loco-regional Melanoma. Clin Plast Surg. 2021 Oct;48(4):631–42.
Knackstedt, Rebecca, et al. “Non-Operative Options for Loco-regional Melanoma.” Clin Plast Surg, vol. 48, no. 4, Oct. 2021, pp. 631–42. Pubmed, doi:10.1016/j.cps.2021.05.007.
Knackstedt R, Smile T, Yu J, Gastman BR. Non-Operative Options for Loco-regional Melanoma. Clin Plast Surg. 2021 Oct;48(4):631–642.
Published In
Clin Plast Surg
DOI
EISSN
1558-0504
Publication Date
October 2021
Volume
48
Issue
4
Start / End Page
631 / 642
Location
United States
Related Subject Headings
- United States
- Surgery
- Skin Neoplasms
- Melanoma
- Immunotherapy
- Humans